Certified by Founder Lodge
Vertex Ventures HC
United States - San Francisco, California
INVESTOR
1 Disclosed Funding Rounds $100,000,000
9 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Vertex Ventures HC is part of a global venture fund network under Vertex Holdings. Vertex Ventures HC invests globally in various sectors of the healthcare industry, including biopharmaceutic
| Company | Date | Round | Raised |
|---|---|---|---|
 Matchpoint Therapeutics |
October, 17 ,2022 | Series A | $100,000,000 |
 GrowthSpace |
August, 16 ,2022 | Series B | $25,000,000 |
 Boundless Bio |
May, 17 ,2023 | Series C | $100,000,000 |
 SpyGlass Pharma, Inc. |
July, 11 ,2023 | Series C | $90,000,000 |
 Septerna |
July, 18 ,2023 | Series B | $150,000,000 |
 EyeBio |
November, 15 ,2023 | Series A | $65,000,000 |
 Neuspera Medical Inc. |
July, 16 ,2024 | Series D | $23,000,000 |
 Indapta Therapeutics |
December, 18 ,2024 | Unknown | $22,500,000 |
 Allay Therapeutics |
June, 06 ,2025 | Series D | $57,500,000 |
Cherry Ventures
Blue Bear Capital
Slow Ventures
Climate Capital
Eniac Ventures
Sizable Energy | $8,000,000 | (Oct 24, 2025)
Sumble | $38,500,000 | (Oct 24, 2025)
Syntracts | $5,300,000 | (Oct 24, 2025)
Cybrid | $10,000,000 | (Oct 24, 2025)
Elevara Medicines | $70,000,000 | (Oct 24, 2025)
